505 related articles for article (PubMed ID: 15167984)
1. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens.
Perrone CE; Ahr HJ; Duan JD; Jeffrey AM; Schmidt U; Williams GM; Enzmann HH
Arch Toxicol; 2004 Oct; 78(10):589-98. PubMed ID: 15167984
[TBL] [Abstract][Full Text] [Related]
2. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.
Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R
Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P.
Ramesh A; Knuckles ME
Cancer Lett; 2006 Aug; 240(2):268-78. PubMed ID: 16288829
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
5. [Comparative ability of three aniline derivatives to alter biotransformation enzymes in rat liver].
Wu K
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 May; 24(3):139-42. PubMed ID: 2253519
[TBL] [Abstract][Full Text] [Related]
6. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs.
Balansky R; Izzotti A; Scatolini L; D'Agostini F; De Flora S
Cancer Res; 1996 Apr; 56(7):1642-7. PubMed ID: 8603414
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of phase II enzyme activity by purpurin resulting in the suppression of MeIQx-DNA-adduct formation in mice.
Takahashi E; Arimoto S; Okamoto K; Negishi T
Mutat Res; 2007 Jan; 626(1-2):128-34. PubMed ID: 17137831
[TBL] [Abstract][Full Text] [Related]
8. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Waddell WJ; Fukushima S; Williams GM
Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
[TBL] [Abstract][Full Text] [Related]
9. Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol.
Wanibuchi H; Wei M; Karim MR; Morimura K; Doi K; Kinoshita A; Fukushima S
Toxicol Pathol; 2006; 34(3):232-6. PubMed ID: 16698719
[TBL] [Abstract][Full Text] [Related]
10. Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.
Whysner J; Montandon F; McClain RM; Downing J; Verna LK; Steward RE; Williams GM
Toxicol Appl Pharmacol; 1998 Jan; 148(1):14-23. PubMed ID: 9465259
[TBL] [Abstract][Full Text] [Related]
11. Effects of route of administration on tissue distribution of DNA adducts in mice: comparison of 7H-dibenzo(c,g)carbazole, benzo(a)pyrene, and 2-acetylaminofluorene.
Schurdak ME; Randerath K
Cancer Res; 1989 May; 49(10):2633-8. PubMed ID: 2713847
[TBL] [Abstract][Full Text] [Related]
12. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
13. The capacity of liver microsomes to form benzo[a]pyrene-diolepoxide-DNA adducts and induction of cytochrome P450 1A in feral fish exposed to pulp mill effluents.
Kantoniemi A; Vähäkangas K; Oikari A
Ecotoxicol Environ Saf; 1996 Nov; 35(2):136-41. PubMed ID: 8950535
[TBL] [Abstract][Full Text] [Related]
14. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
15. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
Eder E; Schuler D; Budiawan
IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
[TBL] [Abstract][Full Text] [Related]
17. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of curcumin in conjunction with piperine on benzo(a)pyrene-mediated DNA adducts and biotransformation enzymes.
Sehgal A; Kumar M; Jain M; Dhawan DK
Nutr Cancer; 2013; 65(6):885-90. PubMed ID: 23909733
[TBL] [Abstract][Full Text] [Related]
20. Assessment of no-observed-effect-levels for DNA adducts formation by genotoxic carcinogens in fetal turkey livers.
Kobets T; Hickey C; Johnson G; Duan JD; Etter S; Smith B; Williams GM
Toxicology; 2024 Jan; 501():153714. PubMed ID: 38141718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
